• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Axsome Therapeutics, Inc. - Common Stock (NQ:AXSM)

    250.50 -1.66 (-0.66%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jun 18, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 770,864
    Open 255.62
    Bid (Size) 247.00 (100)
    Ask (Size) 251.00 (100)
    Prev. Close 252.16
    Today's Range 247.34 - 260.19
    52wk Range 96.09 - 260.19
    Shares Outstanding 47,190,970
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Axsome Therapeutics Highlights the Importance of Brain Health During Alzheimer's & Brain Awareness Month
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗
    All three could become highly prominent biotech companies within 10 years. 
    Via The Motley Fool

    Performance

    YTD
    +40.2%
    +40.2%
    1 Month
    +10.5%
    +10.5%
    3 Month
    +57.7%
    +57.7%
    6 Month
    +70.4%
    +70.4%
    1 Year
    +143.5%
    +143.5%

    More News

    Read More
    News headline image
    Axsome Therapeutics Presents New Data Highlighting its Innovative Sleep Medicine Portfolio at SLEEP 2026
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline ↗
    Via MarketBeat
    Axsome Therapeutics (NASDAQ:AXSM) Q1 Revenue Beat Misses Estimates as Launch Costs Surge ↗
    Via Chartmill
    News headline image
    Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Partners with the Headache Alliance to Highlight the Impact of Migraine During Migraine and Headache Awareness Month
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics to Participate in Upcoming Investor Conferences
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Presents New AUVELITY® Data in Major Depressive Disorder at the American Society of Clinical Psychopharmacology (ASCP) 2026 Annual Meeting
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    This Biotech Is Up 60%. A Top Healthcare Fund Just Bought Another $11 Million ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Axsome Therapeutics Bets on AUVELITY Expansion With June Alzheimer’s Agitation Launch ↗
    Via MarketBeat
    News headline image
    3 Stocks Poised to Disrupt the Healthcare Market by 2030 ↗
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Axsome Therapeutics Recognizes Mental Health Month
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    3 Overlooked Stocks Set to Soar in 2026 ↗
    Via The Motley Fool
    News headline image
    Axsome Therapeutics to Participate in Upcoming Investor Conferences
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Did Axsome Therapeutics Stock Hit Another Record High Today? ↗
    Via The Motley Fool
    News headline image
    Axsome (AXSM) Q1 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Axsome (AXSM) Q2 2025 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Axsome (AXSM) Q1 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Axsome Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Why Axsome Therapeutics Stock Jumped Over 20% in April ↗
    Via The Motley Fool
    News headline image
    Axsome Therapeutics Hosts AUVELITY® FDA Approval Investor Event Featuring Expert Thought Leader
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Axsome Therapeutics Announces FDA Approval of AUVELITY® (dextromethorphan HBr and bupropion HCl) for the Treatment of Agitation Associated with Dementia due to Alzheimer’s Disease
    From Axsome Therapeutics, Inc.
    Via GlobeNewswire
    News headline image
    Is This Healthcare Stock a Millionaire Maker? ↗
    Via The Motley Fool
    Topics Initial Public Offering Intellectual Property

    Frequently Asked Questions

    Is Axsome Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Axsome Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Axsome Therapeutics, Inc. - Common Stock trade on?
    Axsome Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Axsome Therapeutics, Inc. - Common Stock?
    The ticker symbol for Axsome Therapeutics, Inc. - Common Stock is AXSM on the Nasdaq Stock Market
    What is the current price of Axsome Therapeutics, Inc. - Common Stock?
    The current price of Axsome Therapeutics, Inc. - Common Stock is 250.50
    When was Axsome Therapeutics, Inc. - Common Stock last traded?
    The last trade of Axsome Therapeutics, Inc. - Common Stock was at 06/18/26 04:00 PM ET
    What is the market capitalization of Axsome Therapeutics, Inc. - Common Stock?
    The market capitalization of Axsome Therapeutics, Inc. - Common Stock is 11.82B
    How many shares of Axsome Therapeutics, Inc. - Common Stock are outstanding?
    Axsome Therapeutics, Inc. - Common Stock has 12B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.